Rating History for Monte Rosa Therapeutics (GLUE) by Wells Fargo

More Stocks Rated by Wells Fargo | Latest Ratings for GLUE
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
1/8/2026 Derek Archila Maintain Overweight
(Overweight)		 30.00
(22.00)		  
 		   Details